Amalgamated Bank’s Xeris Biopharma Holdings XERS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23K | Hold |
4,834
| – | – | ﹤0.01% | 2066 |
|
2025
Q1 | $27K | Buy |
4,834
+239
| +5% | +$1.34K | ﹤0.01% | 1973 |
|
2024
Q4 | $16K | Hold |
4,595
| – | – | ﹤0.01% | 2222 |
|
2024
Q3 | $13K | Hold |
4,595
| – | – | ﹤0.01% | 2342 |
|
2024
Q2 | $10K | Hold |
4,595
| – | – | ﹤0.01% | 2478 |
|
2024
Q1 | $10K | Sell |
4,595
-14,352
| -76% | -$31.2K | ﹤0.01% | 2467 |
|
2023
Q4 | $45K | Sell |
18,947
-1,367
| -7% | -$3.25K | ﹤0.01% | 2304 |
|
2023
Q3 | $38K | Hold |
20,314
| – | – | ﹤0.01% | 2369 |
|
2023
Q2 | $53K | Buy |
20,314
+1,841
| +10% | +$4.8K | ﹤0.01% | 2298 |
|
2023
Q1 | $30K | Sell |
18,473
-2,776
| -13% | -$4.51K | ﹤0.01% | 2507 |
|
2022
Q4 | $28K | Hold |
21,249
| – | – | ﹤0.01% | 2654 |
|
2022
Q3 | $33K | Buy |
21,249
+337
| +2% | +$523 | ﹤0.01% | 2642 |
|
2022
Q2 | $32K | Buy |
+20,912
| New | +$32K | ﹤0.01% | 2694 |
|